Body and Mind - CEO, Michael Mills
CEO, Michael Mills
Source: Youtube (Capital 10X)
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Cannabis company, Body and Mind (CSE:BAMM), has appointed its Interim CEO, Michael Mills, as its permanent Chief Executive Officer
  • Under Michael’s Interim leadership, the company opened three new revenue-generating facilities in three states in the last three months
  • He also oversaw Body and Mind’s operations throughout the unexpected challenges posed by COVID-19
  • Body and Mind is down 6.18 per cent, and is currently trading for $0.46 per share

Cannabis company, Body and Mind (CSE:BAMM), has appointed its Interim CEO, Michael Mills, as its permanent Chief Executive Officer.

During Michael’s time as an Interim CEO, the company took advantage of a number of opportunities for growth.

Since 2020 started, Body and Mind opened three new revenue-generating facilities in three different US states. These include a production facility in Nevada, a dispensary in San Diego, and a cultivation and dispensary facility in Arkansas.

Michael also oversaw the company’s operations throughout the unexpected challenges posed by the COVID-19 pandemic. A Director of Body and Mind, David Wenger, praised Michael for his work as Interim CEO.

“Michael and the team he leads at Body and Mind have diligently executed on the strategy of debt-free, strategic expansion of the company. 

“Opening three new revenue-producing facilities in the past three months in three states during challenging conditions is a testament to the company’s dedicated personnel and tenacity to move forward with our growth plan, add revenue, and expand the Body and Mind brand presence, production capacity, and dispensary footprint,” he said.

Michael expressed his appreciation for the support he received in moving to the permanent CEO role.

“I look forward to working with our team, expanding our cultivation, production, and dispensary operations across four states. 

“Our new revenue streams and balance sheet with no serviceable debt is a result of our focus on efficiency and measured growth as we continue to build scale,” he said. 

Body and Mind is down 6.18 per cent, and is currently trading for $0.46 per share, as of 3:07pm EST.

More From The Market Herald

" Shoppers Drug Mart exits medical cannabis business

Avicanna has signed a definitive agreement to acquire Shoppers Drug Mart’s medical cannabis business.

" The Market Herald’s Weekly Cannabis Report – May 26, 2023

Tilray Brands Inc. (TSX:TLRY) has received authorization from Italy’s Ministry of Health to distribute three new medical cannabis compounds.

" The Market Herald’s Weekly Cannabis Report – May 19, 2023

PharmaCielo (TSXV:PCLO) has made an initial shipment of CBD Isolate to a specialty biotechnology company based in South Africa.

" This cannabis brand is growing across popular categories

Lifeist’s (TSXV:LFST) subsidiary, CannMart Inc. reported strong sales growth and product breadth expansion.